PureTech News

Press Releases
ALL >
Press Release - 2024-04-16
Wholly Owned Pipeline - LYT-100
Other
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
Press Release - 2024-04-11
Gallop Oncology – LYT-200
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
Press Release - 2024-04-09
Seaport
Other
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
Publications
ALL >
Publications 2024-03-04
Validating the efficacy and value proposition of mental fitness vocal biomarkers in a psychiatric population: prospective cohort study
Publications 2023-04-15
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
Publications 2022-04-13
Cell Host & Microbe: Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

@PureTechH